Dow Up 0.12% Nasdaq Up 1.35%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
366.13 3.52(0.95%)
Prev Close:369.64
Open:N/A
Bid:351.00 x 100
Ask:N/A
1y Target Est:378.70
Beta:0.85
Next Earnings Date: 4-Nov-14REGN Earnings announcement
Day's Range:360.10 - 369.00
52wk Range:257.69 - 376.88
Volume:N/A
Avg Vol (3m):781,257
Market Cap:N/A
P/E (ttm):0.00
EPS (ttm):3.51
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNDown 0.95%N/A
AMGNN/A
NVSN/A
RHHBYN/A

Key Statistics

Forward P/E (1 yr):29.60
P/S (ttm):14.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :10.13
Quarterly EPS Est (Sep-14) :2.57
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.84

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback